NBPF20
gene geneOn this page
Summary
NBPF20 (NBPF member 20, HGNC:32000) is a protein-coding gene on chromosome 1q21.1, encoding NBPF family member NBPF20 (P0DPF2). It is a selective cancer dependency (DepMap: 20.0% of cell lines).
This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes.
Source: NCBI Gene 100288142 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 6 total
- Cancer dependency (DepMap): dependent in 20.0% of screened cell lines
- MANE Select transcript:
NM_001397211
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32000 |
| Approved symbol | NBPF20 |
| Name | NBPF member 20 |
| Location | 1q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000162825 |
| Ensembl biotype | protein_coding |
| OMIM | 614007 |
| Entrez | 100288142 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000369373, ENST00000698833
RefSeq mRNA: 2 — MANE Select: NM_001397211
NM_001278267, NM_001397211
CCDS: CCDS91033
Canonical transcript exons
ENST00000698833 — 143 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001607547 | 145328945 | 145328996 |
| ENSE00001651170 | 145329706 | 145329878 |
| ENSE00001693842 | 145327291 | 145327399 |
| ENSE00001765235 | 145328114 | 145328286 |
| ENSE00003461234 | 145399049 | 145399100 |
| ENSE00003480023 | 145385194 | 145385366 |
| ENSE00003549193 | 145402167 | 145402381 |
| ENSE00003555856 | 145386013 | 145386064 |
| ENSE00003582888 | 145393884 | 145393935 |
| ENSE00003617163 | 145387547 | 145387598 |
| ENSE00003639845 | 145401059 | 145401131 |
| ENSE00003668570 | 145386774 | 145386946 |
| ENSE00003676602 | 145388318 | 145388490 |
| ENSE00003695047 | 145394978 | 145395141 |
| ENSE00003696717 | 145381257 | 145381308 |
| ENSE00003697977 | 145374865 | 145374973 |
| ENSE00003698850 | 145382018 | 145382190 |
| ENSE00003701859 | 145375688 | 145375860 |
| ENSE00003702429 | 145384371 | 145384479 |
| ENSE00003712555 | 145321740 | 145321912 |
| ENSE00003712561 | 145318604 | 145318776 |
| ENSE00003713367 | 145351917 | 145352089 |
| ENSE00003714048 | 145314665 | 145314716 |
| ENSE00003715053 | 145366180 | 145366352 |
| ENSE00003715222 | 145367003 | 145367054 |
| ENSE00003715440 | 145312208 | 145312380 |
| ENSE00003715511 | 145392303 | 145392354 |
| ENSE00003715780 | 145339215 | 145339387 |
| ENSE00003715879 | 145405098 | 145405307 |
| ENSE00003716419 | 145332058 | 145332166 |
| ENSE00003716722 | 145365357 | 145365465 |
| ENSE00003716873 | 145297139 | 145297247 |
| ENSE00003717557 | 145303533 | 145303584 |
| ENSE00003718197 | 145293204 | 145293376 |
| ENSE00003718497 | 145320196 | 145320368 |
| ENSE00003718528 | 145299548 | 145299720 |
| ENSE00003718851 | 145295567 | 145295618 |
| ENSE00003720118 | 145389121 | 145389229 |
| ENSE00003720284 | 145383570 | 145383742 |
| ENSE00003720650 | 145371751 | 145371802 |
| ENSE00003720791 | 145403216 | 145403318 |
| ENSE00003720918 | 145336013 | 145336185 |
| ENSE00003721107 | 145346322 | 145346430 |
| ENSE00003721814 | 145313009 | 145313117 |
| ENSE00003721875 | 145340767 | 145340939 |
| ENSE00003721948 | 145338454 | 145338505 |
| ENSE00003722222 | 145393074 | 145393246 |
| ENSE00003722613 | 145359802 | 145359974 |
| ENSE00003722755 | 145378814 | 145378986 |
| ENSE00003723863 | 145367764 | 145367936 |
| ENSE00003724195 | 145332881 | 145333053 |
| ENSE00003724379 | 145370940 | 145371112 |
| ENSE00003725110 | 145353503 | 145353675 |
| ENSE00003725253 | 145319435 | 145319486 |
| ENSE00003725696 | 145301901 | 145302009 |
| ENSE00003725882 | 145301100 | 145301272 |
| ENSE00003726171 | 145360603 | 145360711 |
| ENSE00003726456 | 145294782 | 145294954 |
| ENSE00003726627 | 145373293 | 145373344 |
| ENSE00003726733 | 145304294 | 145304466 |
| ENSE00003727235 | 145317781 | 145317889 |
| ENSE00003727792 | 145311437 | 145311488 |
| ENSE00003728273 | 145342387 | 145342559 |
| ENSE00003728309 | 145352742 | 145352793 |
| ENSE00003728357 | 145315426 | 145315598 |
| ENSE00003729217 | 145324185 | 145324236 |
| ENSE00003729337 | 145390769 | 145390820 |
| ENSE00003729821 | 145343969 | 145344141 |
| ENSE00003729962 | 145331257 | 145331429 |
| ENSE00003732134 | 145292381 | 145292489 |
| ENSE00003732660 | 145296338 | 145296510 |
| ENSE00003733629 | 145335242 | 145335293 |
| ENSE00003733984 | 145308253 | 145308361 |
| ENSE00003734257 | 145334459 | 145334631 |
| ENSE00003734594 | 145355856 | 145355964 |
| ENSE00003734905 | 145310658 | 145310830 |
| ENSE00003735449 | 145306716 | 145306767 |
| ENSE00003735476 | 145347978 | 145348029 |
| ENSE00003735842 | 145309897 | 145309948 |
| ENSE00003736056 | 145297962 | 145298134 |
| ENSE00003736218 | 145363785 | 145363836 |
| ENSE00003736593 | 145316207 | 145316258 |
| ENSE00003737127 | 145355055 | 145355227 |
| ENSE00003737890 | 145344750 | 145344801 |
| ENSE00003738109 | 145324946 | 145325118 |
| ENSE00003739064 | 145389944 | 145390116 |
| ENSE00003739110 | 145374064 | 145374236 |
| ENSE00003739141 | 145361426 | 145361598 |
| ENSE00003739284 | 145294021 | 145294072 |
| ENSE00003739614 | 145364556 | 145364728 |
| ENSE00003739658 | 145341564 | 145341672 |
| ENSE00003739852 | 145326490 | 145326662 |
| ENSE00003739959 | 145305893 | 145306065 |
| ENSE00003740515 | 145322543 | 145322651 |
| ENSE00003740550 | 145350291 | 145350463 |
| ENSE00003740974 | 145372512 | 145372684 |
| ENSE00003741183 | 145330486 | 145330537 |
| ENSE00003741397 | 145339996 | 145340047 |
| ENSE00003741606 | 145363004 | 145363176 |
| ENSE00003742463 | 145382799 | 145382850 |
| ENSE00003742731 | 145359031 | 145359082 |
| ENSE00003744206 | 145368545 | 145368596 |
| ENSE00003744261 | 145336814 | 145336922 |
| ENSE00003744408 | 145376505 | 145376556 |
| ENSE00003744624 | 145305070 | 145305178 |
| ENSE00003745022 | 145348739 | 145348911 |
| ENSE00003745570 | 145316978 | 145317150 |
| ENSE00003745939 | 145313832 | 145314004 |
| ENSE00003746290 | 145391530 | 145391702 |
| ENSE00003746638 | 145325719 | 145325770 |
| ENSE00003747862 | 145309076 | 145309248 |
| ENSE00003748083 | 145377266 | 145377438 |
| ENSE00003748127 | 145333698 | 145333749 |
| ENSE00003748288 | 145302724 | 145302896 |
| ENSE00003748362 | 145380440 | 145380612 |
| ENSE00003748614 | 145357490 | 145357541 |
| ENSE00003749006 | 145298787 | 145298838 |
| ENSE00003749084 | 145356679 | 145356851 |
| ENSE00003749169 | 145351094 | 145351202 |
| ENSE00003749258 | 145323366 | 145323538 |
| ENSE00003749286 | 145307477 | 145307649 |
| ENSE00003749317 | 145378043 | 145378094 |
| ENSE00003749500 | 145345521 | 145345693 |
| ENSE00003750586 | 145343208 | 145343259 |
| ENSE00003750859 | 145320969 | 145321020 |
| ENSE00003751249 | 145349520 | 145349571 |
| ENSE00003751425 | 145347145 | 145347317 |
| ENSE00003752063 | 145379617 | 145379725 |
| ENSE00003753102 | 145370117 | 145370225 |
| ENSE00003753105 | 145300329 | 145300380 |
| ENSE00003753127 | 145337637 | 145337809 |
| ENSE00003753372 | 145358251 | 145358423 |
| ENSE00003753937 | 145354284 | 145354335 |
| ENSE00003754554 | 145362243 | 145362294 |
| ENSE00003754788 | 145369316 | 145369488 |
| ENSE00003974914 | 145420488 | 145420756 |
| ENSE00003974915 | 145412749 | 145412890 |
| ENSE00003974916 | 145423314 | 145423431 |
| ENSE00003974917 | 145400389 | 145400594 |
| ENSE00003974918 | 145405410 | 145405564 |
| ENSE00003974919 | 145290005 | 145291769 |
| ENSE00003974920 | 145425323 | 145425603 |
| ENSE00003974921 | 145424780 | 145424898 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 92.58.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 92.58 | gold quality |
| cerebellar cortex | UBERON:0002129 | 91.11 | gold quality |
| cerebellum | UBERON:0002037 | 91.07 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.97 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 90.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.37 | gold quality |
| stromal cell of endometrium | CL:0002255 | 87.34 | gold quality |
| tonsil | UBERON:0002372 | 86.41 | gold quality |
| bone marrow cell | CL:0002092 | 85.05 | gold quality |
| liver | UBERON:0002107 | 84.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.11 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.19 | gold quality |
| ventricular zone | UBERON:0003053 | 82.10 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.80 | gold quality |
| cortical plate | UBERON:0005343 | 81.48 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.69 | gold quality |
| bone marrow | UBERON:0002371 | 79.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.97 | gold quality |
| body of pancreas | UBERON:0001150 | 78.76 | gold quality |
| pancreas | UBERON:0001264 | 78.66 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.15 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 77.85 | gold quality |
| lower esophagus | UBERON:0013473 | 77.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.72 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 77.63 | gold quality |
| adrenal gland | UBERON:0002369 | 77.51 | gold quality |
| testis | UBERON:0000473 | 77.21 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.91 | gold quality |
| granulocyte | CL:0000094 | 76.90 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.90 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 17.85 |
| E-ANND-3 | yes | 5.16 |
| E-MTAB-8060 | no | 904.83 |
| E-MTAB-6386 | no | 92.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
68 targeting NBPF20, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-1912-3P | 99.32 | 67.40 | 936 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 20.0% of screened cell lines.
Cross-species orthologs
0 orthologs
Paralogs (14): NBPF3 (ENSG00000142794), NBPF6 (ENSG00000186086), NBPF4 (ENSG00000196427), NBPF1 (ENSG00000219481), NBPF11 (ENSG00000263956), NBPF15 (ENSG00000266338), NBPF12 (ENSG00000268043), NBPF9 (ENSG00000269713), NBPF8 (ENSG00000270231), NBPF14 (ENSG00000270629), (ENSG00000271254), NBPF19 (ENSG00000271383), NBPF10 (ENSG00000271425), NBPF26 (ENSG00000273136)
Protein
Protein identifiers
NBPF family member NBPF20 — P0DPF2 (reviewed: P0DPF2)
Alternative names: Neuroblastoma breakpoint family member 20
All UniProt accessions (2): A0A8V8TMC1, H7BY70
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Miscellaneous. Encoded by one of the numerous copies of NBPF genes clustered in the p36, p12 and q21 region of the chromosome 1.
Similarity. Belongs to the NBPF family.
RefSeq proteins (2): NP_001265196, NP_001384140* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010630 | Olduvai_dom | Domain |
| IPR055306 | NBPF | Family |
Pfam: PF06758
UniProt features (137 total): domain 64, region of interest 42, compositionally biased region 30, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
No AlphaFold model available for P0DPF2 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
chr1q21, MIR3529_3P, MIR141_3P, MIR200A_3P, MIR4778_3P, MIR580_3P, MIR4478, MIR4443, MIR6818_3P, MIR6852_3P, MIR4520_2_3P, MIR6499_3P, MIR152_5P, MIR6832_5P, MIR3929
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
422 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NBPF20 | NOTCH2NLB | P0DPK3 | 507 |
| NBPF20 | CLLU1-AS1 | Q5K130 | 473 |
| NBPF20 | LIX1L | Q8IVB5 | 445 |
| NBPF20 | PPIAL4C | A0A0B4J2A2 | 435 |
| NBPF20 | FAM47A | Q5JRC9 | 419 |
| NBPF20 | ZNF431 | Q8TF32 | 412 |
| NBPF20 | ZNF19 | P17023 | 373 |
| NBPF20 | ACP6 | Q9NPH0 | 370 |
| NBPF20 | GPHRA | B7ZAQ6 | 368 |
| NBPF20 | FMO5 | P49326 | 351 |
| NBPF20 | PEX11B | O96011 | 322 |
| NBPF20 | NUDT17 | P0C025 | 321 |
| NBPF20 | ZNF814 | B7Z6K7 | 321 |
| NBPF20 | ZNF714 | Q96N38 | 318 |
| NBPF20 | NOTCH2NLA | Q7Z3S9 | 313 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A087WUL8, A6NJU9, A6NKU9, A6NNC1, A8MRT5, B2SU53, B5DUH6, C9JG80, E5RHQ5, F8W0I5, P01068, P02849, P02895, P07907, P08519, P0DPF2, P0DPF3, P0DUT2, P13208, P14417, P16881, P20465, P32072, P83060, P96886, Q06602, Q06811, Q13117, Q1HVI8, Q26678, Q26755, Q27905, Q3BBV0, Q4ZJY7, Q5TAG4, Q5TI25, Q60997, Q6P3W6, Q6RY98, Q7T3L1
Diamond homologs: A0A087WUL8, B4DH59, P0C2Y1, P0DPF2, P0DPF3, Q32LC2, Q3BBV0, Q3BBV2, Q5TAG4, Q5TI25, Q5VU43, Q5VWK0, Q6P3W6, Q86T75, Q86XG9, Q8N660, Q96M43, Q9H094, A0A096LNW5, A2RUV0, G3I6Z6, O35516, P0DPK3, P0DPK4, P10040, P21783, P46530, P46531, Q01705, Q04721, Q04756, Q07008, Q20911, Q7Z3S9, Q80YT7, Q99466, Q9QW30, Q9UM47
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2887 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:145292378:G:A | donor_loss | 1.0000 |
| 1:145292379:GGTAA:G | donor_loss | 1.0000 |
| 1:145292381:CAGGT:C | donor_loss | 1.0000 |
| 1:145292383:CCCAG:C | donor_loss | 1.0000 |
| 1:145292409:C:A | donor_gain | 1.0000 |
| 1:145292487:TTT:T | acceptor_gain | 1.0000 |
| 1:145292488:TT:T | acceptor_gain | 1.0000 |
| 1:145293199:CTCA:C | donor_loss | 1.0000 |
| 1:145293201:CACC:C | donor_loss | 1.0000 |
| 1:145293202:A:AC | donor_gain | 1.0000 |
| 1:145293202:ACCT:A | donor_gain | 1.0000 |
| 1:145293202:ACCTC:A | donor_gain | 1.0000 |
| 1:145293203:C:CC | donor_gain | 1.0000 |
| 1:145293203:CCT:C | donor_gain | 1.0000 |
| 1:145293203:CCTC:C | donor_gain | 1.0000 |
| 1:145293203:CCTCC:C | donor_gain | 1.0000 |
| 1:145298017:T:TA | donor_gain | 1.0000 |
| 1:145298130:TGAGC:T | acceptor_gain | 1.0000 |
| 1:145298133:GC:G | acceptor_gain | 1.0000 |
| 1:145298134:CC:C | acceptor_gain | 1.0000 |
| 1:145298135:C:CC | acceptor_gain | 1.0000 |
| 1:145298782:GTTAC:G | donor_loss | 1.0000 |
| 1:145298783:TTAC:T | donor_loss | 1.0000 |
| 1:145298784:TACC:T | donor_loss | 1.0000 |
| 1:145298785:ACCT:A | donor_loss | 1.0000 |
| 1:145298786:CCTG:C | donor_loss | 1.0000 |
| 1:145299546:A:AC | donor_gain | 1.0000 |
| 1:145299546:ACTGT:A | donor_gain | 1.0000 |
| 1:145299547:C:CA | donor_gain | 1.0000 |
| 1:145299547:CTGT:C | donor_gain | 1.0000 |
AlphaMissense
36607 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:145297978:A:C | F4841L | 0.996 |
| 1:145297978:A:T | F4841L | 0.996 |
| 1:145297980:A:G | F4841L | 0.996 |
| 1:145313848:A:C | F4109L | 0.995 |
| 1:145313848:A:T | F4109L | 0.995 |
| 1:145313850:A:G | F4109L | 0.995 |
| 1:145321786:A:C | F3705L | 0.995 |
| 1:145321786:A:T | F3705L | 0.995 |
| 1:145321788:A:G | F3705L | 0.995 |
| 1:145293220:A:C | F5085L | 0.994 |
| 1:145293220:A:T | F5085L | 0.994 |
| 1:145293222:A:G | F5085L | 0.994 |
| 1:145313878:A:C | F4099L | 0.993 |
| 1:145313878:A:T | F4099L | 0.993 |
| 1:145313880:A:G | F4099L | 0.993 |
| 1:145317024:A:C | F3949L | 0.992 |
| 1:145317024:A:T | F3949L | 0.992 |
| 1:145317026:A:G | F3949L | 0.992 |
| 1:145293250:A:C | F5075L | 0.991 |
| 1:145293250:A:T | F5075L | 0.991 |
| 1:145293252:A:G | F5075L | 0.991 |
| 1:145313922:A:G | C4085R | 0.990 |
| 1:145317831:T:A | R3890S | 0.990 |
| 1:145317831:T:G | R3890S | 0.990 |
| 1:145298008:A:C | F4831L | 0.989 |
| 1:145298008:A:T | F4831L | 0.989 |
| 1:145298010:A:G | F4831L | 0.989 |
| 1:145313849:A:G | F4109S | 0.989 |
| 1:145291553:G:C | F5199L | 0.988 |
| 1:145291553:G:T | F5199L | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1043882 (1:145290108 T>A,C), RS1043890 (1:145290097 G>A), RS1058123 (1:145407853 G>A,C), RS1058124 (1:145407850 G>A,T), RS1058125 (1:145407819 G>A,T), RS1064412 (1:145407846 G>C,T), RS1065210 (1:145290100 G>C), RS111226928 (1:145396046 A>G), RS111242368 (1:145411320 T>C), RS111254438 (1:145388710 G>A), RS111383096 (1:145388893 T>C), RS111388002 (1:145397329 C>T), RS111402912 (1:145408255 G>C), RS111403893 (1:145396710 T>A,G), RS111466428 (1:145400981 G>A,C)
Disease associations
OMIM: gene MIM:614007 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005983_40 | Serum uric acid levels | 5.000000e-14 |
| GCST007725_40 | Serum uric acid levels | 6.000000e-14 |
| GCST007733_48 | Serum uric acid levels | 6.000000e-14 |
| GCST007733_68 | Serum uric acid levels | 1.000000e-29 |
| GCST008971_100 | Urate levels | 2.000000e-51 |
| GCST008971_99 | Urate levels | 5.000000e-08 |
| GCST008972_115 | Urate levels | 9.000000e-15 |
| GCST008972_151 | Urate levels | 1.000000e-69 |
| GCST008972_92 | Urate levels | 8.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| aflatoxin B2 | increases methylation | 1 |
| entinostat | decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| abrine | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Pesticides | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases methylation | 1 |
| beta-Naphthoflavone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.